Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard S Gold

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2004
Antimicrobial resistance to linezolidVenkata G Meka, Howard S Gold
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
Enterococcus: an emerging pathogen in hospitalsStephen G Weber, Howard S Gold
Infectious Disease Clinics of North America|January 13, 2009
Antistaphylococcal agentsHoward S Gold, Satish K Pillai
Annals of Internal Medicine|February 7, 2017
Should We Prescribe Antibiotics to This Patient With Persistent Upper Respiratory Symptoms?: Grand Rounds Discussion From Beth Israel Deaconess Medical CenterHoward Libman, Diane M Brockmeyer, Howard S Gold
The New England Journal of Medicine|March 11, 2016
CLINICAL DECISIONS. Skin AbscessMaryAnn B Wilbur, Robert S Daum, Howard S Gold
JAMA Cardiology|October 21, 2020
QT Interval in Patients With COVID-19-ReplyChristina F Yen, David J Shim, Howard S Gold
Archives of Pathology & Laboratory Medicine|January 7, 2009
Optimal use of Myco/F lytic and standard BACTEC blood culture bottles for detection of yeast and mycobacteriaJames E Kirby, Meghan Delaney, Qinfang Qian, et al.
Journal of Clinical Microbiology|July 29, 2011
First report of prosthetic joint infection by Gemella sanguinis and associated "pseudosatelliting" phenomenon on cultureDaniel T Leung, Eric M Davis, Qinfang Qian, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 25, 2014
Rationale for eliminating Staphylococcus breakpoints for β-lactam agents other than penicillin, oxacillin or cefoxitin, and ceftarolineJennifer Dien Bard, Janet A Hindler, Howard S Gold, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2004
The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reportedMaureen K Bolon, Sharon B Wright, Howard S Gold, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2004
Antimicrobial resistance to linezolidVenkata G Meka, Howard S Gold
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
Enterococcus: an emerging pathogen in hospitalsStephen G Weber, Howard S Gold
Infectious Disease Clinics of North America|January 13, 2009
Antistaphylococcal agentsHoward S Gold, Satish K Pillai
Annals of Internal Medicine|February 7, 2017
Should We Prescribe Antibiotics to This Patient With Persistent Upper Respiratory Symptoms?: Grand Rounds Discussion From Beth Israel Deaconess Medical CenterHoward Libman, Diane M Brockmeyer, Howard S Gold
The New England Journal of Medicine|March 11, 2016
CLINICAL DECISIONS. Skin AbscessMaryAnn B Wilbur, Robert S Daum, Howard S Gold
JAMA Cardiology|October 21, 2020
QT Interval in Patients With COVID-19-ReplyChristina F Yen, David J Shim, Howard S Gold
Archives of Pathology & Laboratory Medicine|January 7, 2009
Optimal use of Myco/F lytic and standard BACTEC blood culture bottles for detection of yeast and mycobacteriaJames E Kirby, Meghan Delaney, Qinfang Qian, et al.
Journal of Clinical Microbiology|July 29, 2011
First report of prosthetic joint infection by Gemella sanguinis and associated "pseudosatelliting" phenomenon on cultureDaniel T Leung, Eric M Davis, Qinfang Qian, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 25, 2014
Rationale for eliminating Staphylococcus breakpoints for β-lactam agents other than penicillin, oxacillin or cefoxitin, and ceftarolineJennifer Dien Bard, Janet A Hindler, Howard S Gold, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2004
The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reportedMaureen K Bolon, Sharon B Wright, Howard S Gold, et al.
Pageof 5